These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. The ATPase and ATP-binding functions of P-glycoprotein--modulation by interaction with defined phospholipids. Romsicki Y; Sharom FJ Eur J Biochem; 1998 Aug; 256(1):170-8. PubMed ID: 9746361 [TBL] [Abstract][Full Text] [Related]
26. Interaction of the P-glycoprotein multidrug transporter (MDR1) with high affinity peptide chemosensitizers in isolated membranes, reconstituted systems, and intact cells. Sharom FJ; Yu X; Lu P; Liu R; Chu JW; Szabó K; Müller M; Hose CD; Monks A; Váradi A; Seprôdi J; Sarkadi B Biochem Pharmacol; 1999 Aug; 58(4):571-86. PubMed ID: 10413294 [TBL] [Abstract][Full Text] [Related]
27. Nonionic surfactants increase digoxin absorption in Caco-2 and MDCKII MDR1 cells: Impact on P-glycoprotein inhibition, barrier function, and repeated cellular exposure. Al-Ali AAA; Steffansen B; Holm R; Nielsen CU Int J Pharm; 2018 Nov; 551(1-2):270-280. PubMed ID: 30240828 [TBL] [Abstract][Full Text] [Related]
28. Study of oxidized lipids as endogenous substrates of P-gp (ABCB1). Masuda M; Nakai E; Mizutani T Drug Metab Lett; 2008 Dec; 2(4):238-44. PubMed ID: 19356099 [TBL] [Abstract][Full Text] [Related]
29. Developmental expression of multidrug resistance phosphoglycoprotein (P-gp) in the mouse fetal brain and glucocorticoid regulation. Petropoulos S; Gibb W; Matthews SG Brain Res; 2010 Oct; 1357():9-18. PubMed ID: 20709040 [TBL] [Abstract][Full Text] [Related]
30. Two transport binding sites of P-glycoprotein are unequal yet contingent: initial rate kinetic analysis by ATP hydrolysis demonstrates intersite dependence. Wang EJ; Casciano CN; Clement RP; Johnson WW Biochim Biophys Acta; 2000 Aug; 1481(1):63-74. PubMed ID: 10962093 [TBL] [Abstract][Full Text] [Related]
31. Effects of ursodeoxycholic acid on P-glycoprotein and cytochrome P450 3A4-dependent pharmacokinetics in humans. Becquemont L; Glaeser H; Drescher S; Hitzl M; Simon N; Murdter TE; Heinkele G; Hofmann U; Schaefer C; Burk O; Verstuyft C; Eichelbaum M; Fromm MF Clin Pharmacol Ther; 2006 May; 79(5):449-60. PubMed ID: 16678547 [TBL] [Abstract][Full Text] [Related]
32. Multidrug resistance transporter P-glycoprotein has distinct but interacting binding sites for cytotoxic drugs and reversing agents. Pascaud C; Garrigos M; Orlowski S Biochem J; 1998 Jul; 333 ( Pt 2)(Pt 2):351-8. PubMed ID: 9657975 [TBL] [Abstract][Full Text] [Related]
33. Structure-activity relationship studies of propafenone analogs based on P-glycoprotein ATPase activity measurements. Schmid D; Ecker G; Kopp S; Hitzler M; Chiba P Biochem Pharmacol; 1999 Nov; 58(9):1447-56. PubMed ID: 10513988 [TBL] [Abstract][Full Text] [Related]
34. Simple purification of highly active biotinylated P-glycoprotein: enantiomer-specific modulation of drug-stimulated ATPase activity. Julien M; Kajiji S; Kaback RH; Gros P Biochemistry; 2000 Jan; 39(1):75-85. PubMed ID: 10625481 [TBL] [Abstract][Full Text] [Related]
35. The functional purification of P-glycoprotein is dependent on maintenance of a lipid-protein interface. Callaghan R; Berridge G; Ferry DR; Higgins CF Biochim Biophys Acta; 1997 Sep; 1328(2):109-24. PubMed ID: 9315609 [TBL] [Abstract][Full Text] [Related]
36. Competitive, non-competitive and cooperative interactions between substrates of P-glycoprotein as measured by its ATPase activity. Litman T; Zeuthen T; Skovsgaard T; Stein WD Biochim Biophys Acta; 1997 Aug; 1361(2):169-76. PubMed ID: 9300798 [TBL] [Abstract][Full Text] [Related]
37. Drug-stimulatable ATPase activity in crude membranes of human MDR1-transfected mammalian cells. Ambudkar SV Methods Enzymol; 1998; 292():504-14. PubMed ID: 9711578 [No Abstract] [Full Text] [Related]
38. Selective inhibition of human cytochrome P450 3A4 by N-[2(R)-hydroxy-1(S)-indanyl]-5-[2(S)-(1, 1-dimethylethylaminocarbonyl)-4-[(furo[2, 3-b]pyridin-5-yl)methyl]piperazin-1-yl]-4(S)-hydroxy-2(R)-phenylmethy lpentanamide and P-glycoprotein by valspodar in gene transfectant systems. Kawahara I; Kato Y; Suzuki H; Achira M; Ito K; Crespi CL; Sugiyama Y Drug Metab Dispos; 2000 Oct; 28(10):1238-43. PubMed ID: 10997946 [TBL] [Abstract][Full Text] [Related]